Evaluate the Risk Factors of Mild Cognitive Impairment (MCI) in Patients with Type 2 Diabetes Mellitus (T2DM): A Cross-Sectional Study.
文献摘要
Objective To explore the potential incremental value of metabolic-inflammatory and insulin-resistance indices for diagnosing mild cognitive impairment (MCI) in type 2 diabetes (T2DM), and to furnish new candidate tools and insights for the risk stratification and early recognition of diabetes-related cognitive dysfunction. Methods This cross-sectional, observational study was jointly conducted by two tertiary endocrine centers in northwestern China. A uniform assessment of cognitive status was performed using the Chinese versions of the Montreal Cognitive Assessment (MoCA). MCI was defined as MoCA Results This study included 293 patients with type 2 diabetes mellitus, of whom 187 (63.8%) had mild cognitive impairment (MoCA 0.05). This finding suggests that novel anthropometric and metabolic indices may be linked to cognitive decline primarily through indirect pathways associated with traditional risk factors, offering new mechanistic insights into the obesity-metabolism-cognition axis. Conclusion Univariate analysis revealed that WWI, RFM, and TyG-WtHR were significantly correlated with cognitive decline ( r =0.232, 0.194, and 0.154, respectively; all p<0.01). Incorporation of these three readily obtainable anthropometric and laboratory parameters into the baseline clinical model increased the area under the curve (AUC) from 0.768 to 0.771, offering potential clues into the mechanistic link between obesity-metabolism and cognitive impairment.